New study to inform Australia’s first psychedelics clinical guideline

by

Australia’s first clinical practice guideline on the appropriate use of methylenedioxymethamphetamine-assisted psychotherapy (MDMA-AP) to treat post-traumatic stress disorder (PTSD) is a step closer following the publication of a new Monash-led study.

Leave A Comment

Your email address will not be published. Required fields are marked *